Minimal Differences Between Anti-VEGF Drugs on IOP Over Time

Patients on anti-VEGF therapy may have a small decrease in intraocular pressure (IOP) over time, but with minimal differences between aflibercept, ranibizumab, and bevacizumab, a new large study suggests.
Reuters Health Information

Full Story →